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The eDNA codin~ for the precursor protein or rat li~¢cr mlt~hondrial vitamin D~ 25.hydroxyla~, ¢ylochromo P450tMr~, WaS expres~d under 
the control of the yeast alcohol dehydroBenasc 1 promoter And terminator in Sacrharomy¢~ ¢¢rcvlsla¢ AH22 cell*, The transformed yeast celiac 
produced a P450~Mt=~ protein with an almost similar apparent molecular weillht as ~',ompared with that of the oath,antic matur~ en~me, The expre~- 
sion level of the P4:S0~,M,r..~ hemoprotein was about 5~ I~ molecules per cell as d¢termtBed by reduced CO.diffcrence spectra, The mitoeho=~drial 
fr=tetion prepared from the transformed yeast cells exhibited both 2~.hydroxylase activity toward I=.hydroxyvitamin D:~ and 2?.hydroxyla~ activity 
toward 5/~.cholestane-3~ ?=. 12=.triol in a reconstituted system ¢ontaintnil bovine adrenodoxin and NADPH.adrenodoxin reductaae, 
Vitamin D~ 2$.hydroxyhts¢; C;¢toehrome P450; 5//.Cholestane.3~.7=.12=-trio[ 2"/.hydroxylase; Heteroloilous expression i  yeast 
1. INTRODUCTION 
Vitamin Da (V-Ds) is converted in mammals into the 
active form through two sequential hydroxylation reac- 
tions. The initial hydroxylation at position 25 of V-D~ 
occurs in liver rnicrosomes and/or mitochondria, and 
the subsequent hydroxylation at position lo¢ of 25-hy- 
droxylated V-D~ is in kidney mltochondria [1], 
Masumoto e ta l .  [2] purified V-D3 25-hydroxylase, 
eytochrome P450LMT2S, from mitochondria of female 
rat livers on the basis of monitoring the corresponding 
enzymatic activity. Thereafter, Okuda et al. [3] re- 
ported that the purified 5/3-cholestane.3o~, 7 , 12~-triol 
(THC) 27-hydroxylase also showed 25-hydroxylas¢ ac- 
tivity toward V-Dj. Moreover, Ohyama eta l .  [4,5] 
revealed that a cytochrome P450 species purified from 
mitochondria of rat livers catalyzed both 25-hydroxy- 
lation toward l~-hydro×yvitamin D~(Ia-(OH)-Dj) and 
27-hydroxylation toward THC. Recently, Usui eta l .  
cloned the eDNA coding for rat liver mitochondrial 
P450LMTZ5 [6] and expressed the eDNA in nonsteroido- 
genie COS7 cells, which showed both 25.hydroxylase 
activity toward I~-(OH)-D~ and 27-hydroxylase activity 
toward THC [7]. 
Many of the cloned microsomal P450 cDNAs were 
functionally expressed in the yeast Saccharomyces 
cerevistae [8]. However, functional expression of a 
mitochondrial P450 species in the yeast has not succeed- 
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ed yet. This article reports expression of the mitochon- 
drial P450L~'ra5 cDNA in the yeast, and enzymatic ac- 
tivities of P45(Jt.MT~ produced in the yeast. 
2. MATERIALS AND METHODS 
Restriction enzymes, a Hindlll linker DNA attd an MI3 DEAZA 
sequencing kit were purchased from Takara Shuzo Co, (Kyoto, 
Japan), I¢~.(OH).D~ was obtained from Duphar (Weesp, The 
Netherlands), [~HITHC was synthesized from [)Hlcholic acid 
(Radiochemical Centre, Amersham. UK) according to the method 
described by Bergstr6m and Krabtsch [9], The eDNA clone pLMT25 
[6] for rat liver mitochondrial P45GLMr2s, purified P450t.M-ras and 
anti'P450LMT25 IG[2] were reported previously, S, cerevis~ae 
AH22[Q *l strain was used as a host, wl~ich was obtained by mating 
of AH22[O°] (a, leu2, his4, canl) [clr*] given by Dr Y. Oshima 
(Osaka University, Osaka) with YA'I'[o +] (c~, lea2, /yslO, cyh, karl) 
[cir °] given by Dr A, "rohe (Hiroshima University, Hiroshima) rollow- 
ed by selection on a mininum nutrient agar plate. Recombinant DNA 
procedures were described elsewhere El0], The modified ;,easz ¢~pres- 
sion vector pAAHSN [11] was used for construction of an expresston 
plasmid for P450LMT2S, A P450 hemoprotein i  transformed yeast 
cells was measured by reduced CO-difference spectra [10], Yeast 
cellular proteins were analyzed by Western immunoblotting using 
anti-rat P450LMT~5 IG and [tZSl]anti-mouse IG F(ab')z fragment 
(Amersham Japan, Tokyo) as described [7], Yeast spheroplasts were 
prepared [101, and then subjected to subcellular fractionation [12]. 
P450LMrzs-dependent monooxygenase activities toward Ia.(OH).D~ 
anu THC were assayed as described before [2,31. 
3. RESULTS 
The expression plasmid pAC25 for the precursor pro- 
tein of rat liver mitochondrial P450LMT2S was con- 
structed as shown in Fig. I. Two EcoRI-SacI fragments 
(0.32 kb and 1.85 kb) were prepared from pLMT25 and 
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Fill, 1. Tl~e procedure for construction of the expression plasmid pAC25 for the precursor protein of rat mitochondtial P450Lmr2~, The open box 
indicates the prot©in-codin8 resion for rat P4$0LMT:tS, The open arrows indicate yeast alcohol d©hydrosenase ! (ADH) promoter ant! terminator 
resions. Restriction sites indicated are: Ec, £¢oR1; Nc, Ncol; Sc. $ael; Hd, Hindll[, The synthesized linker LC252, 
~°AATTCAAGCTTAAAAAAATGGCTGTGTTGAGCCGCATGAGACTGAGATGGGCGCTTCTGGACACTCGTGTGATGGGC j' 
~'GTTCGAATTTTTTTACCGACACAACTCGGCGTACTCTGACTCTACCCGCGAAGACCTGTGAGCACACTACCCGGTAC ~' 
then inserted into the EcoRI.SacI site of pUCl9 to yield 
pUC25N and pUC25C, respectively. Replacement of 
the EcoRI.Ncol fragment of pUC25N with the syn- 
thesized EcoRI-NcoI linker DNA (LC252) resulted in 
the construction of pUC25NH, pUC25C was modified 
to yield pUC25CH, in which the original NcoI site in 
the 3' -flanking region was filled-in and ligated to a Hin- 
dil l  linker. From pUC25NH and pUC25CH, both 
HindllI-SacI fragments (0.27 kb and 1.3'7 kb) were 
prepared, respectively, and doubly inserted into the 
Hindll I  site of pAAHSN to yield the expression 
plasmid pAC25. The structure of the constructed 
plasmid was confirmed by DNA sequencing. 
S. cerevisiae AH22 [Q + ] cells were transformed with 
the expression plasmid pAC25 and the vector pAAHS. 
Total cellular protein fractions prepared from the 
recombinant yeast strains were analyzed by Western im- 
munoblotting using anti-rat P450LMr25 IG (Fig. 2). The 
AH22/pAC25 strain (lane 3) contained a protein band 
reacting with anti-P450LMr25 IG at a slightly upper posi- 
tion as compared with that of the authentic mature 
P450LMr2~ (lane 1). The control AH22/pAAH5 strain 
(lane 2) did not contain the corresponding band. The 
apparent molecular weight of the recombinant 
P450Lrar25 protein was smaller than that estimated from 
the eDNA encoding the precursor of P450LMT25. SO, it 
appeared that the mitochondrial signal peptide of the 
rat P450LMT2~ precursor was processed in the yeast, but 
may be differently as compared with in the rat liver. 
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Fig. 3 shows the reduced CO-difference spectra of the 
whole cells of both AH22/pAAH5 (control) and 
AH22/pAC25 strains: A typical P450 peak was found 
in the AH22/pAC25 strain, but not in the control 
strain, indicating that the P450t.MTZs protein produced 
in the yeast contained a protoheme in the molecule. The 
content of the P450Lrar2~ hemoprotein was estimated to 
be about 5 × 104 molecules per cell on the basis of the 
reduced CO-difference spectra. Both mitochondrial 
and microsomal fractions prepared from the recombi- 
nant yeast cells showed a Soret peak at around 450 nm 
(data not shown). The ratio of the P450LMTZ5 hemopro- 
1 ,~ 3 
Fig, 2. Western immunoblotting of the recombinant yeast strain pro- 
ducing P450L~-a'2~ protein. SDS-solubilizcd_ spheroplasts 
prepared from 5 × t0 v transformed yeast cells were analyzed by gel 
transfer immunoassay with anti-rat P4SOLrar2s IG. (Lane 1) The 
purified mature P450.raz2s; (lane 2) the control AH22/pAAH5 strain; 
(lane 3) the AH22/pAC25 strain, The arrow indicates tl~e position 
where the recombinant P450uar2s protein migrates, 
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Fig. 3. Reduced CO.differcnce spectra of the recombinant yeast 
strains. Reduced CO.diffcrcnce spectra of thcl control AH22/pAAH$ 
(...] and AH22/pAC25 (--) strains were measured in O.l M potassium 
phosphate buffer (pH "/,0) at a concentration of lO g ¢ells/m[. 
rein in the mitochondrial nd microsomal fractions was 
roughly estimated to be about 1:1, although a large 
amount of unlysed spheroplasts were in the cell debris 
fraction. 
The mitochondrial fraction prepared from the re- 
combinant yeast cells was assayed for P450LMXas-de- 
pendent monooxygenase activities in an in vitro recon- 
stituted system containing bovine adrenodoxin and 
NADPH-adrenodoxin reductase. The AH22/pAC25 
mitochondrial fraction converted Ic~-(OH)-D~ into 
hx,25-dihydroxyvitamin Da (l~,25.(OH)-D3), while the 
control AH22/pAAH5 mitochondria did not. The turn- 
over number of 25-hydroxvlation toward Ic~-(OHJ-D3 
in the AH22/pAC25 mitochondrial fraction was 
calculated as 0.14 mol product/min • tool P450 (Table 
I ) .  Also, the AH22/pAC25 mitochondria[ fraction 
showed 27-hydroxylation activity toward THe to yield 
5.~-cholestane-3<~,7<x,12a,2?-tetro] (T HC), while the 
control AH22/pAAH5 mitochondria did not, The turn. 
over number was 20 mol product /min,  mol P450 
(Table I). These resalts indicated that the P450LMTZS 
hemoprotein produced in the yeast mito~hondria 
catalyzed both 25-hydroxylation toward Irt,(OH)-D~ 
and 27-hydroxylation toward THC,  although the tur- 
nover number for THC 27.hydroxylation was much 
higher than that for Ic<.(OH)-D~ 2$-hydroxyla;Mn, 
4. DISCUSSION 
The amino acid sequence deduced from the nucleo. 
tide sequence of  the cDNA for rat liver mitochondrial 
P450L~Tas revealed that the enzyme consists o f  501 
~:,nino acid residues preceded by 32 amino acid signal 
sequence [6]. We constructed the yeast expression 
plasrnid for the precursor protein of rat P450LMT:IS in- 
cluding the signal sequence. The P450t.M'n~ protein pro- 
duced in the yeast contained a protoheme and located in 
both mitochondrial and microsomal fractions. 
However, there was a possibility of  contamination of  
P450LM~2~ into the microsomes from the m~tochondrial 
P450LMT:5 durit~g fractionation, The mitochondrial 
fraction prepared from the recombinant yeast cells ex. 
hibited both 25-hydroxylase activity toward I<x-(OH)- 
D~ (0.14 tool/rain,  tool P450) and 27-hydroxylase ac- 
tivity toward THC (20 mol /min,  mol P450) in the in 
vitro reconstituted system. These turnover numbers of  
the P450LMT2t produced in the yeast mitochondria were 
less than those of  P450LMTa~ purified from rat liver 
mitochondria (1,4 tool l<x,2S,(OH)a-Dffmin • mot P¢.~0 
and 36.0 mol TeHC/min  • mol P450) [5], particularly in 
the assay using I~-(OH)-Da as substrate, However, we 
must be careful for comparison of these turnover 
numbers obtained under different assay conditions, 
We h ave reported that S. cerevisiae was suited for the 
functional expression of  microsomal P450 monooxy- 
genase enzymes and their modified ones [8]. The pre- 
sent study also showed that the yeast was suitable for 
expression o f  the mitochondrial P450LM'ra~. Several 
mitochondrial P450 species such as P450scc [13], 
P450tta [14], P450LMT2S [7], P450cc24 [15] and sterol 
26 (o r  27 )-hydroxylase [16] were expressed in 
nonsteroidogenic COS cells. However, the correspon. 
ding P450 hemoproteins were not detected by the reduc- 
ed CO-difference spectrum. This may be in part due to 
low expression levels of the heterologous genes in the 
COS cells. In addition, on the in v ivo assays fo r  
Table I 
Monooxygenase ctivities of the mitochondrial fraction prepared from the recombinant yeast cells expressing P450LMT2~ inan in vitro reconstituted 
system 
Monooxygenase activity" (mol/min, mol P450) Mitochondrial fraction prepared from the 
recombinant yeast strain 25.Hydro×ylase ctivity toward I~.(OI-~).D~ 27- Hydroaylase activity toward THC 
AH22/pAAH5 N.D. N.D. 
AH22/pAC25 0.14 20 
"'['he monooxygenase ctivities were measured in a reconstituted system containing the mitochonflrial fraction prepared from the indicated recom- 
binant yeast strain. The reaction mixture (0.5 ml) contained 4 pmol mitochondrial P450LMT~/63 /~g protein, 0.2 unh/ml bovine NADPH- 
adrenodoxin reductase, 8 ~M bovine adrenodoxin, a substrate (200 ~.M Ia-(OH)=D3 or 28/~M [3HITHC), 100 mM Tris-HCl buffer, pH 7.8, and 
0.5 mM EDTA. The reaction was started by addition of NADPH to a final concentration f 100 mM. After incubation at 37°C for I0 rain, the 
reaction mixture was analyzed by HPLC for In-(OH)- D3 25-hydroxylation a d by TLC for THC 27-hydroxylation 
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P450u, ms-dependent monooxygenase activities, the ex- 
ogenously added labeled sttbstrates were probably 
di luted with the endogenous substrates presefl~ in the 
serum medium.  So,  it is reasonab le  to presume that the  
monooxygenase activities calculated from the radioac- 
t ivity were possibly anderestin~atcd. On ¢he other hand, 
the recombinant AH22/pAC25 yeast ce~i~ produced a 
fair ly large amount o f  P450~m'rzs and contained no en- 
dogenous substrates  fo r  the enzyme,  Therefore ,  the 
P450LMnpdependent  activities were easily rnea~urcd 
under low background conditions, 
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